Cargando…
Assessment of Sequelae of COVID-19 Nearly 1 Year After Diagnosis
Background: A previous study has shown that 81% of the COVID-19 patients had mild or moderate symptoms. However, most studies on the sequelae in COVID-19 patients focused on severe cases and the long-term follow-up studies on the health consequences in non-severe cases are limited. The current study...
Autores principales: | Zhou, Fangyuan, Tao, Meihui, Shang, Luorui, Liu, Yuhan, Pan, Guangtao, Jin, Yan, Wang, Li, Hu, Shaoke, Li, Jinxiao, Zhang, Mengqi, Fu, Yu, Yang, Shenglan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649686/ https://www.ncbi.nlm.nih.gov/pubmed/34888318 http://dx.doi.org/10.3389/fmed.2021.717194 |
Ejemplares similares
-
Emodin Protects Sepsis Associated Damage to the Intestinal Mucosal Barrier Through the VDR/ Nrf2 /HO-1 Pathway
por: Shang, Luorui, et al.
Publicado: (2021) -
EMT‐associated microRNAs and their roles in cancer stemness and drug resistance
por: Pan, Guangtao, et al.
Publicado: (2021) -
Integrated network pharmacology and experimental verification to investigate the mechanisms of YYFZBJS against colorectal cancer via CDK1/PI3K/Akt signaling
por: Li, Jinxiao, et al.
Publicado: (2022) -
Long‐term effects of obesity on COVID‐19 patients discharged from hospital
por: Shang, Luorui, et al.
Publicado: (2021) -
Emodin Attenuates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis Signaling Pathway In vitro and In vivo
por: Liu, Yuhan, et al.
Publicado: (2021)